.png)
Key Information
Chief Investigator: Dr Jonathan Krell
ICTU collaboration: Operations; Statistics;Database
Email: dice-trial@imperial.ac.uk
Study website: Clinical trials
Trial registration: EudraCT Number: 2016-000065-23
Clinical Trial. Gov: NCT03648489
Status: Follow-up
DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high grade serous type, and carcinosarcoma)
An international multi-centre randomised phase II study to assess the efficacy of TAK228 in combination with intravenous weekly paclitaxel compared with weekly paclitaxel alone in women with advanced/recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high grade serous type, and carcinosarcoma)
Therapeutic areas contacts
For contact details please visit Therapeutic areas contacts